The future of nanosized radiation enhancers

British Journal of Radiology

Volumn 88, Issue 1054, 2015, Pages

  Pottier, Agnes ^a   Borghi, Elsa ^a   Levy, Laurent ^a  

^a NANOBIOTIX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE;

ANATOMICAL CONCEPTS; CANCER PATIENT; CANCER RADIOTHERAPY; DIAGNOSTIC IMAGING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; NONHUMAN; RADIATION EXPOSURE; RADIOACTIVITY; REVIEW; TREATMENT OUTCOME; COMPUTER ASSISTED RADIOTHERAPY; NEOPLASMS; PROCEDURES; RADIATION DOSE; TRENDS;

HUMANS; NANOPARTICLES; NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84942134636     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20150171     Document Type: Review

References (14)

1. Glide-Hurst CK, Chetty IJ. Improving radiotherapy planning, delivery accuracy, and normal tissue sparing using cutting edge technologies. J Thorac Dis 2014; 6: 303-18. doi: 10.3978/j.issn.2072-1439.2013.11.10
2. Citrin DE, Mitchell JB. Altering the response to radiation: sensitizers and protectors. Semin Oncol 2014; 41: 848-59. doi: 10.1053/j. seminoncol.2014.09.013
3. Maggiorella L, Barouch G, Devaux C, Pottier A, Deutsch E, Bourhis J, et al. Nanoscale radiotherapy with hafnium oxide nanoparticles. Future Oncol 2012; 8: 1167-81. doi: 10.2217/fon.12.96
4. Leung MK, Chow JC, Chithrani BD, Lee MJ, Oms B, Jaffray DA. Irradiation of gold nanoparticles by X-rays: Monte Carlo simulation of dose enhancements and the spatial properties of the secondary electrons production. Med Phys 2011; 38: 624-31. doi: 10.1118/1.3539623
5. McMahon SJ, Hyland WB, Muir MF, Coulter JA, Jain S, Butterworth KT, et al. Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy. Radiother Oncol 2011; 100: 412-16. doi: 10.1016/j. radonc.2011.08.026
6. Marill J, Anesary NM, Zhang P, Vivet S, Borghi E, Levy L, et al. Hafnium oxide nanoparticles: toward an in vitro predictive biological effect? Radiat Oncol 2014; 9: 150. doi: 10.1186/1748-717X-9-150
7. Coulter JA, Hyland WB, Nicol J, Currell FJ. Radiosensitising nanoparticles as novel cancer therapeutics-pipe dream or realistic prospect? Clin Oncol (R Coll Radiol) 2013; 25: 593-603. doi: 10.1016/j.clon.2013.06.011
8. Sancey L, Lux F, Kotb S, Roux S, Dufort S, Bianchi A, et al. The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy. Br J Radiol 2014; 87: 20140134. doi: 10.1259/bjr.20140134
9. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 2004; 49: N309-15. doi: 10.1088/0031-9155/49/18/N03
10. Bonvalot S, Le Pechoux C, De Baere T, Buy X, Italiano A, Stockle E, et al. Phase I study of NBTXR3 nanoparticles, in patients with advanced soft tissue sarcoma (STS). J Clin Oncol 2014; 32(Suppl. 5s); abstr 10563.
11. Nguyen NP, Davis R, Bose SR, Dutta S, Vinh-Hung V, Chi A, et al. Potential applications of image-guided radiotherapy for radiation dose escalation in patients with early stage high-risk prostate cancer. Front Oncol 2015; 5:18. doi: 10.3389/fonc.2015.00018
12. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brnnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368: 987-98. doi: 10.1056/NEJMoa1209825
13. Klein J, Dawson LA. Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities. Int J Radiat Oncol Biol Phys 2013; 87: 22-32. doi: 10.1016/j. ijrobp.2012.08.043
14. Blanco R, Maestu I, de la Torre MG, Cassinello A, Nuez I. A review of the management of elderly patients with non-small-cell lung cancer. Ann Oncol 2015; 26: 451-63. doi: 10.1093/annonc/mdu268